Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

NCT03057145 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Prexasertib
DRUG: Olaparib

Sponsor

Geoffrey Shapiro, MD, PhD

Collaborators

[object Object]
[object Object]